Sales and Marketing

Showing 15 posts of 11528 posts found.

Donald Trump nominates Dr Stephen Hahn as next FDA Commissioner

November 4, 2019 Medical Communications, Sales and Marketing Donald Trump, FDA, Ned Sharpless, President trump, Scott Gottlieb, Trump, US

The US FDA could be set to receive its next long-term Commissioner after the White House revealed President Donald Trump’s …

China green lights first novel Alzheimer’s therapy since 2003

November 4, 2019 Sales and Marketing Alzheimer's, China, Green Valley, Oligomannate, pharma

Shanghai Green Valley Pharmaceuticals has announced that its therapy Oligomannate (GV-971) has secured marketing approval from China’s National Medical Products Administration (NMPA) …

Promising Phase 3 data for Sanofi’s Toujeo secures CHMP recommendation of label expansion in type 1 diabetes

November 4, 2019 Research and Development, Sales and Marketing EU, Sanofi, Type 1 diabetes, diabetes, pharma, toujeo

Sanofi took the opportunity at the International Society for Pediatric and Adolescent Diabetes 45th Annual Conference in Boston, Massachusetts to …

Amgen drops $2.7bn to acquire stake in Chinese biotech in bid to expand in the region

November 1, 2019 Medical Communications, Research and Development, Sales and Marketing Amgen, BeiGene, Cancer, China, deal, oncology, pharma

Amgen has signed an agreement with Chinese biotech BeiGene to acquire a 20.5% stake in the latter, in a bid …

Transactions in the pharma sector: Through the EU merger review looking-glass

October 31, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mergers, mergers and acquisitions, pharma

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) …

FDA committee votes to pull US approval for AMAG’s preterm birth drug Makena

October 31, 2019 Sales and Marketing FDA, Makena, pharma

An FDA committee has passed a contentious vote recommending by a slim majority for the withdrawal of existing approval of …

The November 2019 issue of Pharmafocus is available to read for free online now!

October 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The latest monthly edition of Pharmafocus, the November issue, is available to read for free online now!

FDA approves Biogen and Alkermes’ Vumerity for relapsing multiple sclerosis

October 30, 2019 Research and Development, Sales and Marketing Alkermes, Biogen, FDA, Vumerity, multiple sclerosis, pharma

The FDA has given the green light to Vumerity (diroximel fumarate), a novel oral fumarate developed by Biogen and Alkermes, …

Expanded EU label for Benlyta now covers paediatric lupus patients

October 30, 2019 Research and Development, Sales and Marketing Benlyta, Europe, GSK, Lupus, pharma

GlaxoSmithKline is celebrating the news that the European Commission has chosen to approve an expansion to the label of its …

European Commission approves Sanofi’s Dupixent in chronic rhinosinusitis with nasal polyposis

October 30, 2019 Research and Development, Sales and Marketing Dupixent, EU, Sanofi, pharma

Sanofi’s Dupixent (dupilumab) has secured European approval for the treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP), it has emerged. …

Bavencio+Inlyta combo OK’d in Europe for first-line advanced kidney cancer

October 29, 2019 Manufacturing and Production, Sales and Marketing Bavencio, Cancer, Kidney cancer, Merck KGaA, Pfizer, inlyta, pharma

Merck KGaA and Pfizer’s joint drug Bavencio (avelumab) has received European approval in combination with Inlyta (axitinib) in the first-line …

Deeper patient insights for stronger patient outcomes

October 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing eyeforpharma, pharma

Patient insights are crucial. As you already know, they are the key to the creation of successful, targeted programmes and …

Gilead’s filgotinib combos fall short in lupus and Sjögren’s syndrome

October 28, 2019 Research and Development, Sales and Marketing Gilead, Lupus, filgotinib, pharma

Gilead’s impending regulatory submission of its JAK inhibitor filgotinib to the FDA for the treatment of rheumatoid arthritis has been …

UKRI and BBSRC award £170m to 3 UK universities for biotech and biology PhD studentships

October 28, 2019 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, pharma, research

The Biotechnology and Biological Sciences Research Council (BBSRC) and UK Research and Innovation (UKRI) have awarded a funding injection of …
The Gateway to Local Adoption Series

Latest content